Promising genetic biomarkers of preclinical Alzheimer's disease: The influence of APOE and TOMM40 on brain integrity

International Journal of Alzheimer's Disease

Volumn , Issue , 2012, Pages

  Ferencz, Beata ^a   Karlsson, Sari ^a   Kalpouzos, Grégoria ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; CARRIER PROTEIN; TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 40; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN REGION; GENE LINKAGE DISEQUILIBRIUM; GENETIC MARKER; HUMAN; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; TEMPORAL LOBE;

EID: 84861091750     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2012/421452     Document Type: Review

References (126)

1. Hebert L. E., Scherr P. A., Bienias J. L., Bennett D. A., Evans D. A., Alzheimer disease in the US population: prevalence estimates using the 2000 census (Pubitemid 36975801)
2. Petersen R. C., Doody R., Kurz A., Mohs R. C., Morris J. C., Rabins P. V., Ritchie K., Rossor M., Thal L., Winblad B., Current concepts in mild cognitive impairment Archives of Neurology 2001 58 12 1985 1992 (Pubitemid 33143977)
3. Qiu C., Kivipelto M., Aguero-Torres H., Winblad B., Fratiglioni L., Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex Journal of Neurology, Neurosurgery and Psychiatry 2004 75 6 828 833 (Pubitemid 38658502)
4. Petersen R. C., Clinical trials for early (pre-dementia) Alzheimer's disease: a case for mild cognitive impairment The Journal of Nutrition, Health and Aging 2010 14 4 304 305
5. Anderson J. W., Schmitter-Edgecombe M., Mild cognitive impairment and feeling-of-knowing in episodic memory Journal of Clinical and Experimental Neuropsychology 2010 32 5 505 514
6. Grinberg L. T., Rub U., Ferretti R. E., Nitrini R., Farfel J. M., Polichiso L., Gierga K., Jacob-Filho W., Heinsen H., The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset? Neuropathology and Applied Neurobiology 2009 35 4 406 416
7. Braak H., Del Tredici K., The pathological process underlying Alzheimer's disease in individuals under thirty Acta Neuropathologica 2011 121 2 171 181
8. Johnson D. K., Barrow W., Anderson R., Harsha A., Honea R., Brooks W. M., Burns J. M., Diagnostic utility of cerebral white matter integrity in early Alzheimer's disease International Journal of Neuroscience 2010 120 8 544 550
9. Du A. T., Schuff N., Zhu X. P., Jagust W. J., Miller B. L., Reed B. R., Kramer J. H., Mungas D., Yaffe K., Chui H. C., Weiner M. W., Atrophy rates of entorhinal cortex in AD and normal aging Neurology 2003 60 3 481 486 (Pubitemid 36188246)
10. Braak H., Braak E., Neuropathological stageing of Alzheimer-related changes Acta Neuropathologica 1991 82 4 239 259
11. Raz N., Rodrigue K. M., Differential aging of the brain: patterns, cognitive correlates and modifiers Neuroscience and Biobehavioral Reviews 2006 30 6 730 748 (Pubitemid 44292292)
12. Serra L., Cercignani M., Lenzi D., Perri R., Fadda L., Caltagirone C., MacAluso E., Bozzali M., Grey and white matter changes at different stages of Alzheimer's disease Journal of Alzheimer's Disease 2010 19 1 147 159
13. Pennanen C., Kivipelto M., Tuomainen S., Hartikainen P., Hnninen T., Laakso M. P., Hallikainen M., Vanhanen M., Nissinen A., Helkala E. L., Vainio P., Vanninen R., Partanen K., Soininen H., Hippocampus and entorhinal cortex in mild cognitive impairment and early AD Neurobiology of Aging 2004 25 3 303 310 (Pubitemid 38220965)
14. Bartzokis G., Cummings J. L., Sultzer D., Henderson V. W., Nuechterlein K. H., Mintz J., White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study Archives of Neurology 2003 60 3 393 398 (Pubitemid 36314365)
15. Thompson P. M., Mega M. S., Woods R. P., Zoumalan C. I., Lindshield C. J., Blanton R. E., Moussai J., Holmes C. J., Cummings J. L., Toga A. W., Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas Cerebral Cortex 2001 11 1 1 16 (Pubitemid 32064172)
16. O'Dwyer L., Lamberton F., Bokde A. L., Ewers M., Faluyi Y. O., Tanner C., Mazoyer B., O'Neill D., Bartley M., Collins D. R., Coughlan T., Prvulovic D., Hampel H., Using diffusion tensor imaging and mixed-effects models to investigate primary and secondary white matter degeneration in Alzheimer's disease and mild cognitive impairment Journal of Alzheimer's Disease 2011 26 4 667 682
17. Sexton C. E., Kalu U. G., Filippini N., Mackay C. E., Ebmeier K. P., A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease Neurobiology of Aging 2011 32 12 2322.e5 2322.e18
18. Flicker C., Ferris S. H., Reisberg B., Mild cognitive impairment in the elderly: predictors of dementia Neurology 1991 41 7 1006 1009
19. Petersen R. C., Smith G. E., Waring S. C., Ivnik R. J., Tangalos E. G., Kokmen E., Mild cognitive impairment: clinical characterization and outcome Archives of Neurology 1999 56 3 303 308 (Pubitemid 29120227)
20. Petersen R. C., Roberts R. O., Knopman D. S., Boeve B. F., Geda Y. E., Ivnik R. J., Smith G. E., Jack C. R., Mild cognitive impairment: ten years later Archives of Neurology 2009 66 12 1447 1455
21. Gauthier S., Reisberg B., Zaudig M., Petersen R. C., Ritchie K., Broich K., Belleville S., Brodaty H., Bennett D., Chertkow H., Cummings J. L., de Leon M., Feldman H., Ganguli M., Hampel H., Scheltens P., Tierney M. C., Whitehouse P., Winblad B., Mild cognitive impairment Lancet 2006 367 9518 1262 1270
22. Dubois B., Albert M. L., Amnestic MCI or prodromal Alzheimer's disease? Lancet Neurology 2004 3 4 246 248 (Pubitemid 38373663)
23. Jack C. R., Knopman D. S., Jagust W. J., Shaw L. M., Aisen P. S., Weiner M. W., Petersen R. C., Trojanowski J. Q., Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade The Lancet Neurology 2010 9 1 119 128
24. Tondelli M., Wilcock G. K., Nichelli P., De Jager C. A., Jenkinson M., Zamboni G., Structural MRI changes detectable up to ten years before clinical Alzheimer's disease Neurobiology of Aging 2012 33 4 e825 e836
25. Bckman L., Jones S., Berger A. K., Laukka E. J., Small B. J., Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis Neuropsychology 2005 19 4 520 531 (Pubitemid 41077134)
26. Stein J. L., Hua X., Morra J. H., Lee S., Hibar D. P., Ho A. J., Leow A. D., Toga A. W., Sul J. H., Kang H. M., Eskin E., Saykin A. J., Shen L., Foroud T., Pankratz N., Huentelman M. J., Craig D. W., Gerber J. D., Allen A. N., Corneveaux J. J., Stephan D. A., Webster J., DeChairo B. M., Potkin S. G., Jack C. R., Weiner M. W., Thompson P. M., Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease NeuroImage 2010 51 2 542 554
27. Potkin S. G., Guffanti G., Lakatos A., Turner J. A., Kruggel F., Fallon J. H., Saykin A. J., Orro A., Lupoli S., Salvi E., Weiner M., Macciardi F., Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's Disease PLoS One 2009 4 8, article e6501
28. Roses A. D., On the discovery of the genetic association of apolipoprotein E genotypes and common late-onset Alzheimer disease Journal of Alzheimer's Disease 2006 9 3 361 366 (Pubitemid 44253329)
29. Pievani M., Galluzzi S., Thompson P. M., Rasser P. E., Bonetti M., Frisoni G. B., APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease NeuroImage 2011 55 3 909 919
30. Roses A. D., Lutz M. W., Amrine-Madsen H., Saunders A. M., Crenshaw D. G., Sundseth S. S., Huentelman M. J., Welsh-Bohmer K. A., Reiman E. M., A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease Pharmacogenomics Journal 2010 10 5 375 384
31. Roses A. D., An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease Archives of Neurology 2010 67 5 536 541
32. Li H., Wetten S., Li L., Jean P. L. S., Upmanyu R., Surh L., Hosford D., Barnes M. R., Briley J. D., Borrie M., Coletta N., Delisle R., Dhalla D., Ehm M. G., Feldman H. H., Fornazzari L., Gauthier S., Goodgame N., Guzman D., Hammond S., Hollingworth P., Hsiung G. Y., Johnson J., Kelly D. D., Keren R., Kertesz A., King K. S., Lovestone S., Loy-English I., Matthews P. M., Owen M. J., Plumpton M., Pryse-Phillips W., Prinjha R. K., Richardson J. C., Saunders A., Slater A. J., George -. P. H. S., Stinnett S. W., Swartz J. E., Taylor R. L., Wherrett J., Williams J., Yarnall D. P., Gibson R. A., Irizarry M. C., Middleton L. T., Roses A. D., Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease Archives of Neurology 2008 65 1 45 53
33. Abraham R., Moskvina V., Sims R., A genome-wide association study for late-onset Alzheimer's disease using DNA pooling Biomedcentral Medical Genomics 2008 1, article 44
34. Grupe A., Abraham R., Li Y., Rowland C., Hollingworth P., Morgan A., Jehu L., Segurado R., Stone D., Schadt E., Karnoub M., Nowotny P., Tacey K., Catanese J., Sninsky J., Brayne C., Rubinsztein D., Gill M., Lawlor B., Lovestone S., Holmans P., O'Donovan M., Morris J. C., Thal L., Goate A., Owen M. J., Williams J., Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants Human Molecular Genetics 2007 16 8 865 873 (Pubitemid 47064316)
35. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M. L., Pahwa J. S., Moskvina V., Dowzell K., Williams A., Jones N., Thomas C., Stretton A., Morgan A. R., Lovestone S., Powell J., Proitsi P., Lupton M. K., Brayne C., Rubinsztein D. C., Gill M., Lawlor B., Lynch A., Morgan K., Brown K. S., Passmore P. A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A. D., Love S., Kehoe P. G., Hardy J., Mead S., Fox N., Rossor M., Collinge J., Maier W., Jessen F., Schrmann B., Van Den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frlich L., Hampel H., Hll M., Rujescu D., Goate A. M., Kauwe J. S. K., Cruchaga C., Nowotny P., Morris J. C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P. P., Van Broeckhoven C., Livingston G., Bass N. J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C. E., Tsolaki M., Singleton A. B., Guerreiro R., Mhleisen T. W., Nthen M. M., Moebus S., Jckel K. H., Klopp N., Wichmann H. E., Carrasquillo M. M., Pankratz V. S., Younkin S. G., Holmans P. A., O'Donovan M., Owen M. J., Williams J., Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Nature Genetics 2009 41 10 1088 1093
36. Feulner T. M., Laws S. M., Friedrich P., Wagenpfeil S., Wurst S. H. R., Riehle C., Kuhn K. A., Krawczak M., Schreiber S., Nikolaus S., Frstl H., Kurz A., Riemenschneider M., Examination of the current top candidate genes for AD in a genome-wide association study Molecular Psychiatry 2010 15 7 756 766
37. Yu C. E., Seltman H., Peskind E. R., Galloway N., Zhou P. X., Rosenthal E., Wijsman E. M., Tsuang D. W., Devlin B., Schellenberg G. D., Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association Genomics 2007 89 6 655 665 (Pubitemid 46719797)
38. Mancuso M., Calsolaro V., Orsucci D., Mitochondria, cognitive impairment, and Alzheimer's disease International Journal of Alzheimers Disease 2009 2009 8
39. Devi L., Prabhu B. M., Galati D. F., Avadhani N. G., Anandatheerthavarada H. K., Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction Journal of Neuroscience 2006 26 35 9057 9068 (Pubitemid 44319397)
40. Swerdlow R. H., Brain aging, Alzheimer's disease, and mitochondria Biochimica et Biophysica Acta 2011 1812 12 1630 1639
41. Baloyannis S. J., Mitochondria are related to synaptic pathology in Alzheimer's disease International Journal of Alzheimer's Disease 2011 2011 7
42. Pedersen N. L., Posner S. F., Gatz M., Multiple-threshold models for genetic influences on age of onset for Alzheimer disease: findings in swedish twins American Journal of Medical Genetics-Neuropsychiatric Genetics 2001 105 8 724 728 (Pubitemid 33101472)
43. Mahley R. W., Weisgraber K. H., Huang Y., Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 2006 103 15 5644 5651
44. Bckman L., Memory and cognition in preclinical dementia: what we know and what we do not know Canadian Journal of Psychiatry 2008 53 6 354 360
45. Karas G. B., Scheltens P., Rombouts S. A., Visser P. J., Van Schijndel R. A., Fox N. C., Barkhof F., Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease NeuroImage 2004 23 2 708 716 (Pubitemid 39370621)
46. Smith C. D., Chebrolu H., Wekstein D. R., Schmitt F. A., Jicha G. A., Cooper G., Markesbery W. R., Brain structural alterations before mild cognitive impairment Neurology 2007 68 16 1268 1273 (Pubitemid 46625972)
47. Fjell A. M., Walhovd K. B., Fennema-Notestine C., McEvoy L. K., Hagler D. J., Holland D., Brewer J. B., Dale A. M., CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease Journal of Neuroscience 2010 30 6 2088 2101
48. Tapiola T., Pennanen C., Tapiola M., Tervo S., Kivipelto M., Hnninen T., Pihlajamki M., Laakso M. P., Hallikainen M., Hmlinen A., Vanhanen M., Helkala E. L., Vanninen R., Nissinen A., Rossi R., Frisoni G. B., Soininen H., MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study Neurobiology of Aging 2008 29 1 31 38 (Pubitemid 350102714)
49. Stoub T. R., Bulgakova M., Leurgans S., Bennett D. A., Fleischman D., Turner D. A., DeToledo-Morrell L., MRI predictors of risk of incident Alzheimer disease: a longitudinal study Neurology 2005 64 9 1520 1524 (Pubitemid 40617686)
50. Stoub T. R., deToledo-Morrell L., Stebbins G. T., Leurgans S., Bennett D. A., Shah R. C., Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 2006 103 26 10041 10045 (Pubitemid 43993619)
51. Chételat G., Fouquet M., Kalpouzos G., Denghien I., De la Sayette V., Viader F., Mézenge F., Landeau B., Baron J. C., Eustache F., Desgranges B., Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry Neuropsychologia 2008 46 6 1721 1731
52. Stoub T. R., Rogalski E. J., Leurgans S., Bennett D. A., deToledo-Morrell L., Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function Neurobiology of Aging 2010 31 7 1089 1098
53. Driscoll I., Davatzikos C., An Y., Wu X., Shen D., Kraut M., Resnick S. M., Longitudinal pattern of regional brain volume change differentiates normal aging from MCI Neurology 2009 72 22 1906 1913
54. Chételat G., Desgranges B., Landeau B., Mézenge F., Poline J. B., De La Sayette V., Viader F., Eustache F., Baron J. C., Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease Brain 2008 131 1 60 71
55. Buckner R. L., Snyder A. Z., Shannon B. J., LaRossa G., Sachs R., Fotenos A. F., Sheline Y. I., Klunk W. E., Mathis C. A., Morris J. C., Mintun M. A., Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory Journal of Neuroscience 2005 25 34 7709 7717 (Pubitemid 41208641)
56. Fjell A. M., Amlien I. K., Westlye L. T., Stenset V., Fladby T., Skinningsrud A., Eilsertsen D. E., Bjrnerud A., Walhovd K. B., CSF biomarker pathology correlates with a medial temporo-parietal network affected by very mild to moderate Alzheimer's disease but not a fronto-striatal network affected by healthy aging NeuroImage 2010 49 2 1820 1830
57. Karas G., Sluimer J., Goekoop R., Van Der Flier W., Rombouts S. A. R. B., Vrenken H., Scheltens P., Fox N., Barkhof F., Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease American Journal of Neuroradiology 2008 29 5 944 949 (Pubitemid 351684972)
58. Hogan A. M., Vargha-Khadem F., Saunders D. E., Kirkham F. J., Baldeweg T., Impact of frontal white matter lesions on performance monitoring: ERP evidence for cortical disconnection Brain 2006 129 8 2177 2188 (Pubitemid 44289080)
59. Salat D. H., Tuch D. S., van der Kouwe A. J., Greve D. N., Pappu V., Lee S. Y., Hevelone N. D., Zaleta A. K., Growdon J. H., Corkin S., Fischl B., Rosas H. D., White matter pathology isolates the hippocampal formation in Alzheimer's disease Neurobiology of Aging 2010 31 2 244 256
60. Kalus P., Slotboom J., Gallinat J., Mahlberg R., Cattapan-Ludewig K., Wiest R., Nyffeler T., Buri C., Federspiel A., Kunz D., Schroth G., Kiefer C., Examining the gateway to the limbic system with diffusion tensor imaging: the perforant pathway in dementia NeuroImage 2006 30 3 713 720
61. Villain N., Fouquet M., Baron J. C., Mézenge F., Landeau B., De La Sayette V., Viader F., Eustache F., Desgranges B., Chételat G., Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease Brain 2010 133 11 3301 3314
62. Salat D. H., Greve D. N., Pacheco J. L., Quinn B. T., Helmer K. G., Buckner R. L., Fischl B., Regional white matter volume differences in nondemented aging and Alzheimer's disease NeuroImage 2009 44 4 1247 1258
63. Witter M. P., The perforant path: projections from the entorhinal cortex to the dentate gyrus Progress in Brain Research 2007 163 43 61 (Pubitemid 47321428)
64. Reisberg B., Franssen E. H., Hasan S. M., Monteiro I., Boksay I., Souren L. E. M., Kenowsky S., Auer S. R., Elahi S., Kluger A., Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer's and other dementing processes European Archives of Psychiatry and Clinical Neuroscience 1999 249 3 28 36
65. Frazer K. A., Murray S. S., Schork N. J., Topol E. J., Human genetic variation and its contribution to complex traits Nature Reviews Genetics 2009 10 4 241 251
66. Gatz M., Reynolds C. A., Fratiglioni L., Johansson B., Mortimer J. A., Berg S., Fiske A., Pedersen N. L., Role of genes and environments for explaining Alzheimer disease Archives of General Psychiatry 2006 63 2 168 174 (Pubitemid 43213878)
67. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D., Apolipoprotein E: high-avidity binding to -amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 1993 90 5 1977 1981 (Pubitemid 23069980)
68. Saunders A., Trowers M. K., Shimkets R. A., Blakemore S., Crowther D. J., Mansfield T. A., Wallace D. M., Strittmatter W. J., Roses A. D., The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection Biochimica et Biophysica Acta 2000 1502 1 85 94 (Pubitemid 30433858)
69. Farrer L. A., Cupples L. A., Haines J. L., Hyman B., Kukull W. A., Mayeux R., Myers R. H., Pericak-Vance M. A., Risch N., Van Duijn C. M., Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis Journal of the American Medical Association 1997 278 16 1349 1356 (Pubitemid 27449696)
70. Bartzokis G., Acetylcholinesterase inhibitors may improve myelin integrity Biological Psychiatry 2007 62 4 294 301 (Pubitemid 47454515)
71. Hofer S. M., Christensen H., Mackinnon A. J., Korten A. E., Jorm A. F., Henderson A. S., Easteal S., Change in cognitive functioning associated with ApoE genotype in a community sample of older adults Psychology of Aging 2002 17 2 194 208 (Pubitemid 34568636)
72. Nilsson L. G., Adolfsson R., Bckman L., Cruts M., Nyberg L., Small B. J., Van Broeckoven C., The influence of APOE status on episodic and semantic memory: data from a population-based study Neuropsychology 2006 20 6 645 657 (Pubitemid 44747863)
73. Ryan L., Walther K., Bendlin B. B., Lue L. F., Walker D. G., Glisky E. L., Age-related differences in white matter integrity and cognitive function are related to APOE status NeuroImage 2011 54 2 1565 1577
74. Small B. J., Rosnick C. B., Fratiglioni L., Bckman L., Apolipoprotein E and cognitive performance: a meta-analysis Psychology and Aging 2004 19 4 592 600 (Pubitemid 39603405)
75. McKhann G. M., Knopman D. S., Chertkow H., Hyman B. T., Jack C. R. Jr., Kawas C. H., Klunk W. E., Koroshetz W. J., Manly J. J., Mayeux R., Mohs R. C., Morris J. C., Rossor M. N., Scheltens P., Carrillo M. C., Thies B., Weintraub S., Phelps C. H., The diagnosis of dementia due to Alzheimer's disease: recommendations from the national institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimer's and Dementia 2011 7 3 263 269
76. Mayeux R., Saunders A. M., Shea S., Mirra S., Evans D., Roses A. D., Hyman B. T., Crain B., Tang M. X., Phelps C. H., Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease The New England Journal of Medicine 1998 338 8 506 511 (Pubitemid 28103134)
77. Elias-Sonnenschein L. S., Viechtbauer W., Ramakers I. H., Verhey F. R. J., Visser P. J., Predictive value of APOE- 4 allele for progression from MCI to AD-type dementia: a meta-analysis Journal of Neurology, Neurosurgery and Psychiatry 2011 82 10 1149 1156
78. Jones L., Harold D., Williams J., Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease Biochimica et Biophysica Acta 2010 1801 8 754 761
79. Hirsch-Reinshagen V., Burgess B. L., Wellington C. L., Why lipids are important for Alzheimer disease? Molecular and Cellular Biochemistry 2009 326 1 121 129
80. Hardy J., Allsop D., Amyloid deposition as the central event in the aetiology of Alzheimer's disease Trends in Pharmacological Sciences 1991 12 10 383 388
81. Poirier J., Apoliprotein E in animal models of CNS injury and in Alzheimer's disease Trends in Neurosciences 1994 17 12 525 530
82. Poirier J., Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism Annals of the New York Academy of Sciences 2000 924 81 90 (Pubitemid 32050187)
83. Swerdlow R. H., Khan S. M., A mitochondrial cascade hypothesis for sporadic Alzheimer's disease Medical Hypotheses 2004 63 1 8 20 (Pubitemid 38887104)
84. Castellani R. J., Lee H., Siedlak S. L., Nunomura A., Hayashi T., Nakamura M., Zhu X., Perry G., Smith M. A., Reexamining Alzheimer's disease: evidence for a protective role for amyloid- protein precursor and amyloid- Journal of Alzheimer's Disease 2009 18 2 447 452
85. Shen L., Kim S., Risacher S. L., Nho K., Swaminathan S., West J. D., Foroud T., Pankratz N., Moore J. H., Sloan C. D., Huentelman M. J., Craig D. W., DeChairo B. M., Potkin S. G., Jack C. R., Weiner M. W., Saykin A. J., Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: a study of the ADNI cohort NeuroImage 2010 53 3 1051 1063
86. Espeseth T., Westlye L. T., Fjell A. M., Walhovd K. B., Rootwelt H., Reinvang I., Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E 4 Neurobiology of Aging 2008 29 3 329 340 (Pubitemid 351215592)
87. Zhang D., Wang Y., Zhou L., Yuan H., Shen D., Multimodal classification of Alzheimer's disease and mild cognitive impairment NeuroImage 2011 53 3 856 867
88. Spampinato M., Rumboldt Z., Hosker R. J., Mintzer J. E., Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease Radiology 2011 258 3 843 852
89. Zhang H., Trollor J. N., Wen W., Zhu W., Crawford J. D., Kochan N. A., Slavin M. J., Brodaty H., Reppermund S., Kang K., Mather K. A., Sachdev P. S., Grey matter atrophy of basal forebrain and hippocampus in mild cognitive impairment Journal of Neurology, Neurosurgery and Psychiatry 2011 82 5 487 493
90. Bendlin B. B., Ries M. L., Canu E., Sodhi A., Lazar M., Alexander A. L., Carlsson C. M., Sager M. A., Asthana S., Johnson S. C., White matter is altered with parental family history of Alzheimer's disease Developmental Neuropsychology 2010 35 3 257 277
91. Pievani M., Rasser P. E., Galluzzi S., Benussi L., Ghidoni R., Sabattoli F., Bonetti M., Binetti G., Thompson P. M., Frisoni G. B., Mapping the effect of APOE 4 on gray matter loss in Alzheimer's disease in vivo NeuroImage 2009 45 4 1090 1098
92. Filippini N., Rao A., Wetten S., Gibson R. A., Borrie M., Guzman D., Kertesz A., Loy-English I., Williams J., Nichols T., Whitcher B., Matthews P. M., Anatomically-distinct genetic associations of APOE 4 allele load with regional cortical atrophy in Alzheimer's disease NeuroImage 2009 44 3 724 728
93. Barber R., Gholkar A., Scheltens P., Ballard C., McKeith I. G., Morris C. M., O'Brien J. T., Apolipoprotein E 4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias Archives of Neurology 1999 56 8 961 965 (Pubitemid 29374813)
94. He J., Farias S., Martinez O., Reed B., Mungas D., DeCarli C., Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes Archives of Neurology 2009 66 11 1393 1399
95. Hamalainen A., Grau-Olivares M., Tervo S., Niskanen E., Pennanen C., Huuskonen J., Kivipelto M., Hnninen T., Tapiola M., Vanhanen M., Hallikainen M., Helkala E. L., Nissinen A., Vanninen R. L., Soininen H., Apolipoprotein E 4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study Neurodegenerative Diseases 2008 5 3-4 186 189 (Pubitemid 351347846)
96. Bartzokis G., Lu P. H., Geschwind D. H., Edwards N., Mintz J., Cummings J. L., Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia Archives of General Psychiatry 2006 63 1 63 72 (Pubitemid 43037470)
97. Persson J., Lind J., Larsson A., Ingvar M., Cruts M., Van Broeckhoven C., Adolfsson R., Nilsson L. G., Nyberg L., Altered brain white matter integrity in healthy carriers of the APOE 4 allele: a risk for AD? Neurology 2006 66 7 1029 1033 (Pubitemid 44044786)
98. Johnson S. C., La Rue A., Hermann B. P., The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE epsilon3/epsilon3 genotype Alzheimer's Dementia 2011 7 4 456 465
99. Schmidt R., Schmidt H., Haybaeck J., Loitfelder M., Weis S., Cavalieri M., Seiler S., Enzinger C., Ropele S., Erkinjuntti T., Pantoni L., Scheltens P., Fazekas F., Jellinger K., Heterogeneity in age-related white matter changes Acta Neuropathologica 2011 122 2 171 185
100. Bertram L., McQueen M. B., Mullin K., Blacker D., Tanzi R. E., Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database Nature Genetics 2007 39 1 17 23 (Pubitemid 46026496)
101. Huang W., Qiu C., Von Strauss E., Winblad B., Fratiglioni L., APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study Archives of Neurology 2004 61 12 1930 1934 (Pubitemid 39612954)
102. Yang J., Benyamin B., McEvoy B. P., Gordon S., Henders A. K., Nyholt D. R., Madden P. A., Heath A. C., Martin N. G., Montgomery G. W., Goddard M. E., Visscher P. M., Common SNPs explain a large proportion of the heritability for human height Nature Genetics 2010 42 7 565 569
103. Kirkwood T. B., Cordell H. J., Finch C. E., Speed-bumps ahead for the genetics of later-life diseases Trends in Genetics 2011 27 10 387 388
104. Eichler E. E., Flint J., Gibson G., Kong A., Leal S. M., Moore J. H., Nadeau J. H., Missing heritability and strategies for finding the underlying causes of complex disease Nature Reviews Genetics 2010 11 6 446 450
105. Lin M. T., Beal M. F., Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 2006 443 7113 787 795 (Pubitemid 44622683)
106. Mancuso M., Calsolaro V., Orsucci D., Siciliano G., Murri L., Is there a primary role of the mitochondrial genome in Alzheimer's disease? Journal of Bioenergetics and Biomembranes 2009 41 5 411 416
107. McBride H. M., Neuspiel M., Wasiak S., Mitochondria: more than just a powerhouse Current Biology 2006 16 14 551 560
108. Trifunovic A., Wredenberg A., Falkenberg M., Spelbrink J. N., Rovio A. T., Bruder C. E., Bohlooly-Y M., Gldlf S., Oldfors A., Wibom R., Trnell J., Jacobs H. T., Larsson N. G., Premature ageing in mice expressing defective mitochondrial DNA polymerase Nature 2004 429 6990 417 423 (Pubitemid 38715133)
109. Swerdlow R. H., Kish S. J., Mitochondria in Alzheimer's disease International Review of Neurobiology 2002 53 341 385
110. Sultana R., Butterfield D. A., Oxidatively modified, mitochondria- relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment Journal of Bioenergetics and Biomembranes 2009 41 5 441 446
111. Reddy P. H., Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease Experimental Neurology 2009 218 2 286 292
112. Scheffler I. E., Mitochondria 2008 2nd Hoboken, NJ, USA John Wiley Sons
113. Humphries A. D., Streimann I. C., Stojanovski D., Johnston A. J., Yano M., Hoogenraad N. J., Ryan M. T., Dissection of the mitochondrial import and assembly pathway for human Tom40 Journal of Biological Chemistry 2005 280 12 11535 11543 (Pubitemid 40418465)
114. Manczak M., Anekonda T. S., Henson E., Park B. S., Quinn J., Reddy P. H., Mitochondria are a direct site of A accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression Human Molecular Genetics 2006 15 9 1437 1449
115. Kim S., Swaminathan S., Shen L., Genome-wide association study of CSF biomarkers A 1-42, t-, and p- 181p in the ADNI cohort Neurology 2011 76 1 69 79
116. Ankarcrona M., Mangialasche F., Winblad B., Rethinking Alzheimer's disease therapy: are mitochondria the key? Journal of Alzheimer's Disease 2010 20 suppl.2 S579 S590
117. Osherovich L., TOMMorrow's AD marke Science-Business eXchange 2009 2 30 1165
118. Hong M. G., Alexeyenko A., Lambert J. C., Amouyel P., Prince J. A., Genome-wide pathway analysis implicates intracellular transmembrane protein transport in Alzheimer disease Journal of Human Genetics 2010 55 10 707 709
119. Lagergren M., Fratiglioni L., Hallberg I. R., Berglund J., Elmsthl S., Hagberg B., Holst G., Rennemark M., Sjlund B. M., Thorslund M., Wiberg I., Winblad B., Wimo A., A longitudinal study integrating population, care and social services data. The swedish national study on aging and care (SNAC) Aging and Clinical Experimental Research 2004 16 2 158 168 (Pubitemid 38714058)
120. Ferencz B., Karlsson S., Kalpouzos G., Differential influence of APOE TOMM40 on brain integrity and congnition: implications for biomarker potentialin Alzheimer's disease. in preparation
121. Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L. M., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D., Roses A. D., Binding of human apolipoprotein E to synthetic amyloid peptide: isoform-specific effects and implications for late-onset Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 1993 90 17 8098 8102 (Pubitemid 23260862)
122. Sanan D. A., Weisgraber K. H., Russell S. J., Mahley R. W., Huang D., Saunders A., Schmechel D., Wisniewski T., Frangione B., Roses A. D., Strittmatter W. J., Apolipoprotein E associates with amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform ApoE4 associates more efficiently than ApoE3 Journal of Clinical Investigation 1994 94 2 860 869
123. Ye S., Huang Y., Mullendorff K., Dong L., Giedt G., Meng E. C., Cohen F. E., Kuntz I. D., Weisgraber K. H., Mahley R. W., Apolipoprotein (apo) E4 enhances amyloid peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target Proceedings of the National Academy of Sciences of the United States of America 2005 102 51 18700 18705 (Pubitemid 43011289)
124. Miquel J., Economos A. C., Fleming J., Johnson J. E., Mitochondrial role in cell aging Experimental Gerontology 1980 15 6 575 591 (Pubitemid 11243249)
125. Remmen H. V., Richardson A., Oxidative damage to mitochondria and aging Experimental Gerontology 2001 36 7 957 968 (Pubitemid 32519578)
126. Eckert A., Schmitt K., Gotz J., Mitochondrial dysfunction-the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-beta toxicity Alzheimer's Research and Therapy 2011 3 2 15